DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Megace (Megestrol) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Megace (Megestrol) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (43)
Death (5)
Life Threatening Events (3)

Reports by Reaction Type

Vomiting (17)Abdominal Pain (16)Headache (16)Fatigue (16)Malaise (16)Cognitive Disorder (16)Vaginal Haemorrhage (9)Anaemia (8)Confusional State (6)Mental Status Changes (4)Hypokalaemia (4)Uterine Leiomyoma (4)

Below are a few examples of reports where side effects / adverse reactions may be related to Megace (Megestrol). For a complete list or a specific selection of reports, please use the links above.

Possible Megace side effects in

Reported by a consumer/non-health professional from Norway on 2012-07-11

Patient:

Reactions: Generalised Erythema, Renal Impairment, Rash

Drug(s) suspected as cause:
Megace



Possible Megace side effects in 81 year old male

Reported by a consumer/non-health professional from United States on 2012-06-21

Patient: 81 year old male, weighing 52.0 kg (114.4 pounds)

Reactions: Confusional State, Balance Disorder

Drug(s) suspected as cause:
Megace
    Administration route: Oral
    Indication: Weight Decreased
    Start date: 2012-04-27
    End date: 2012-04-30

Megace
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2012-04-27
    End date: 2012-04-30

Namenda
    Dosage: form: tabs
    Administration route: Oral
    Indication: Dementia
    Start date: 2012-04-27
    End date: 2012-04-30

Other drugs received by patient: Nexium; Glucosamine; Flomax; Multi-Vitamins; Asmanex Twisthaler; Exelon; Spiriva



Possible Megace side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-08

Patient: female, weighing 74.8 kg (164.7 pounds)

Reactions: Deep Vein Thrombosis

Drug(s) suspected as cause:
Megace
    Dosage: 400, 2x daily, po
    Administration route: Oral
    Indication: Appetite Disorder
    Start date: 2012-05-27
    End date: 2012-05-31

Megace
    Dosage: 400, 2x daily, po
    Administration route: Oral
    Indication: Appetite Disorder
    Start date: 2012-05-17
    End date: 2012-05-20



Possible Megace side effects in 81 year old male

Reported by a consumer/non-health professional from United States on 2012-05-22

Patient: 81 year old male, weighing 52.0 kg (114.4 pounds)

Reactions: Confusional State, Balance Disorder

Drug(s) suspected as cause:
Megace
    Indication: Weight Decreased
    Start date: 2012-04-27
    End date: 2012-04-30

Namenda
    Dosage: form: tabs
    Administration route: Oral
    Indication: Dementia
    Start date: 2012-04-27
    End date: 2012-04-30

Megace
    Indication: Decreased Appetite
    Start date: 2012-04-27
    End date: 2012-04-30

Other drugs received by patient: Flomax; Spiriva; Nexium; Exelon; Asmanex Twisthaler; Multi-Vitamins; Glucosamine



Possible Megace side effects in 75 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10

Patient: 75 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Vomiting, Nausea, Dehydration, Blood Glucose Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metformin HCL
    Start date: 2012-03-07

Decadron
    Indication: Premedication
    Start date: 2012-02-08

Megace
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2012-04-12

Other drugs received by patient: Lovastatin; Insulin; Kytril; Aspirin; Centrum; Vitamin B-12



Possible Megace side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08

Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)

Reactions: Anaemia, Uterine Leiomyoma, Gastrooesophageal Reflux Disease, Decreased Appetite, Hypokalaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoprolol Tartrate
    Dosage: 25 mg (25 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16

Axitinib (Axitinib)
    Dosage: 10 mg (5 mg, 2 in 1 d), oral; 6 mg (3 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Axitinib (Axitinib)
    Dosage: 10 mg (5 mg, 2 in 1 d), oral; 6 mg (3 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-11-30

Carboplatin
    Dosage: (670 mg), intravenous; 26.9048 mg (565 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-09-22
    End date: 2011-09-22

Carboplatin
    Dosage: (670 mg), intravenous; 26.9048 mg (565 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Paclitaxel
    Dosage: (300 mg), intravenous; 10.2381 mg (215 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-09-22
    End date: 2011-09-22

Paclitaxel
    Dosage: (300 mg), intravenous; 10.2381 mg (215 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Prempro
    Dosage: 0.625mg/2.5mg (1 in 1 d), oral;
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Celecoxib
    Dosage: 200 mg (200 mg, 1 in 1 d), oral; 200 mg (200 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Megace
    Dosage: 5 cc (5, 1 in 1 d), oral; 5 cc (5, 1 in 1 d), oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27

Megace
    Dosage: 5 cc (5, 1 in 1 d), oral; 5 cc (5, 1 in 1 d), oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-11-28

Other drugs received by patient: Benadryl; MS Contin; Zofran; Wellbutrin



Possible Megace side effects in 79 year old male

Reported by a consumer/non-health professional from Italy on 2012-05-03

Patient: 79 year old male

Reactions: Hyperthyroidism

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Megace
    Dosage: 160 mg per square meter of body surface/day interr on 31oct2011
    Administration route: Oral
    Indication: Increased Appetite
    Start date: 2011-09-25

Cordarone
    Administration route: Oral
    Indication: Arrhythmia
    Start date: 2011-10-18
    End date: 2011-11-10

Other drugs received by patient: Tamsulosin HCL; Allopurinol; Levothyroxine Sodium; Zanedip



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: female, weighing 65.9 kg (145.0 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 565 mg, every 3 weeks
    Start date: 2011-10-20
    End date: 2011-10-20

Metoprolol Tartrate
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Axitinib
    Dosage: 3 mg, 2x/day, continuously
    Administration route: Oral
    Start date: 2011-11-30

Paclitaxel
    Dosage: 215 mg, every 3 weeks
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral

Carboplatin
    Dosage: 670 mg, unk
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-09-22
    End date: 2011-09-22

Prempro
    Dosage: 0.625 mg/2.5 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Paclitaxel
    Dosage: 300 mg, unk
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-09-22
    End date: 2011-09-22

Megace
    Dosage: 5cc, 1x/day
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Megace
    Dosage: 5 cc, 1x/day
    Administration route: Oral
    Start date: 2011-11-28

Other drugs received by patient: MS Contin; Benadryl; Wellbutrin; Zofran



Possible Megace side effects in 81 year old male

Reported by a consumer/non-health professional from United States on 2012-04-25

Patient: 81 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Weight Decreased, Diarrhoea, Drug Ineffective

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Megace
    Dosage: stopped

Plavix
    Dosage: prescription#: 6188960
    Start date: 2011-10-01



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-19

Patient: female

Reactions: Overdose, Thrombocytopenia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Dosage: citalopram overdose: 60 mg daily
    Administration route: Oral
    Indication: Depression
    Start date: 2012-01-19
    End date: 2012-02-10

Megace
    Dosage: 1 df
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2012-02-03
    End date: 2012-02-05

Megace
    Dosage: 3 df
    Administration route: Oral
    Start date: 2012-02-06
    End date: 2012-02-09

Other drugs received by patient: Calcium Gluconate; Pentasa; Vitamin B1 and B6; Bricanyl; Aluminum Hydroxide and Magnesium Trisilicate; Imodium; Decan; Magnesium Sulfate; Ascorbic Acid; Atrovent; Aspirin; Aldalix; Olimel; Cernevit-12; Phocytan; Nexium; Lovenox; Prednisolone; Fluticasone Propionate / Salmeterol; Singulair



Possible Megace side effects in 82 year old female

Reported by a physician from France on 2012-04-11

Patient: 82 year old female

Reactions: Thrombocytopenia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Administration route: Oral
    Indication: Depression
    Start date: 2012-01-19
    End date: 2012-02-10

Megace
    Dosage: 1df:1tab 3,4feb12-5feb12,3tabs 6,7feb12-9feb12
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2012-02-03
    End date: 2012-02-09

Other drugs received by patient: Prednisolone; Imodium; Vitamin B1 TAB; Vitamin B6; Aldalix; Pentasa; Aspirin; Calcium Gluconate; Aluminum Hydroxide and Magnesium Trisilicate; Bricanyl; Cernevit-12; Fluticasone Propionate / Salmeterol; Phocytan; Magnesium Sulfate; Ascorbic Acid; Singulair; Atrovent; Nexium; Lovenox



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-04

Patient: female

Reactions: Overdose, Thrombocytopenia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Dosage: citalopram overdose: 60 mg daily
    Administration route: Oral
    Indication: Depression
    Start date: 2012-01-19
    End date: 2012-02-10

Megace
    Dosage: 1 df
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2012-02-03
    End date: 2012-02-05

Megace
    Dosage: 3 df
    Administration route: Oral
    Start date: 2012-02-06
    End date: 2012-02-09

Other drugs received by patient: Aldalix; Fluticasone Propionate / Salmeterol; Aluminum Hydroxide and Magnesium Trisilicate; Decan; Aspirin; Cernevit-12; Magnesium Sulfate; Bricanyl; Pentasa; Olimel; Vitamin B1 and B6; Singulair; Calcium Gluconate; Ascorbic Acid; Atrovent; Imodium; Nexium; Lovenox; Phocytan; Prednisolone



Possible Megace side effects in 79 year old male

Reported by a consumer/non-health professional from Italy on 2012-04-03

Patient: 79 year old male

Reactions: Hyperthyroidism

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Megace
    Dosage: 160 mg per square meter of body surface/day interr on 31oct2011
    Administration route: Oral
    Indication: Increased Appetite
    Start date: 2011-09-25

Cordarone
    Administration route: Oral
    Indication: Arrhythmia
    Start date: 2011-10-18
    End date: 2011-11-10

Other drugs received by patient: Allopurinol; Zanedip; Levothyroxine Sodium; Tamsulosin HCL



Possible Megace side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29

Patient: 56 year old female, weighing 84.0 kg (184.8 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoprolol Tartrate
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Prempro
    Dosage: 1 df: 0.625mg/2.5mg
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Axitinib
    Dosage: from 30nov2011:3mg twice/daily 5mg twicw daily,2 wks on , 1wk off
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Megace
    Dosage: 1 df: 5cc 5ml/day from 28nov11
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Celebrex
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Carboplatin
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Administration route: Oral
    Indication: Menopause
    Start date: 2007-01-01
    End date: 2011-11-01

Paclitaxel
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Other drugs received by patient: MS Contin; Wellbutrin; Benadryl; Zofran



Possible Megace side effects in 79 year old male

Reported by a consumer/non-health professional from Italy on 2012-03-28

Patient: 79 year old male

Reactions: Hyperthyroidism

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cordarone
    Administration route: Oral
    Indication: Arrhythmia
    Start date: 2011-10-18
    End date: 2011-11-10

Megace
    Dosage: 160 mg per square meter of body surface/day interr on 31oct2011
    Administration route: Oral
    Indication: Increased Appetite
    Start date: 2011-09-25

Other drugs received by patient: Allopurinol; Tamsulosin HCL; Zanedip; Levothyroxine Sodium



Possible Megace side effects in 66 year old female

Reported by a physician from United States on 2012-03-23

Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)

Reactions: Confusional State, Abdominal Pain, Vomiting, Mental Status Changes, Headache, Cognitive Disorder, Fatigue, Malaise

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lortab
    Dosage: every 6 hours as needed (5mg/500mg)
    Indication: Pain
    Start date: 2009-04-02
    End date: 2009-06-29

Megace
    Administration route: Oral
    Indication: Appetite Disorder

Radiation
    Dosage: qd 5 days a week, x 3weeks external beam 2d
    Start date: 2009-03-16
    End date: 2009-04-06

Colace
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Study Medication
    Dosage: wk1: 5 mg am,wk2: 5 mg am and 5 mg pm,wk3: 10mg am and 5 mg pm,wk4-24:10 mg am and 10 mg pm
    Indication: Prophylaxis
    Start date: 2009-05-12
    End date: 2009-07-07

Ranitidine
    Indication: Ulcer
    End date: 2009-08-28

Zofran
    Dosage: every 6 hours as needed
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Simvastatin
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Fergon
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2009-02-27
    End date: 2009-08-28

Sunitinib Malate
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Pioglitazone HCL
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Other drugs received by patient: Artificial Tear; Aspirin; Actonel; Aspirin; Aspirin; Ciprofloxacin Hydrochloride; Extra Strength Tylenol



Possible Megace side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-22

Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)

Reactions: Confusional State, Abdominal Pain, Vomiting, Blood Urea Increased, Nausea, Mental Status Changes, Cognitive Disorder, Headache, Pallor, Malaise, Fatigue, Posterior Reversible Encephalopathy Syndrome, Disturbance in Attention, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ferrous Gluconate (Ferrous Gluconate) Tablet
    Dosage: 325 mg, bid, oral
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2009-02-27
    End date: 2009-08-28

Lortab
    Dosage: 1 df every 6 hours as needed
    Indication: Analgesic Therapy
    Start date: 2009-08-25
    End date: 2009-08-28

Lortab
    Dosage: 1 df every 6 hours as needed
    Indication: Analgesic Therapy
    Start date: 2009-04-02
    End date: 2009-06-29

Zofran
    Dosage: 1 df every 6 hours as needed, oral
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Uncodeable ^unclassifiable^ (Uncodeable ^unclassifiable^)
    Dosage: qd 5 days a week x 3 weeks
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-03-16
    End date: 2009-04-06

Megace
    Dosage: 3 df, qd, oral
    Administration route: Oral
    Indication: Appetite Disorder

Simvastatin
    Dosage: 40 mg, bid
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Sunitinib Malate
    Dosage: 50 mg, bid
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Ranitidine
    Dosage: 150 mg, bid
    Indication: Ulcer
    End date: 2009-08-28

Pioglitazone
    Dosage: 30 mg, qd, oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Uncodeable ^investigational Drug^ (Uncodeable ^investigational Drug^)
    Indication: Prophylaxis
    Start date: 2009-05-12
    End date: 2009-07-07

Colace (Docusate Sodium)
    Dosage: 100 mg, bid
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Other drugs received by patient: Artificial Tears; Aspirin; Actonel



Possible Megace side effects in 66 year old female

Reported by a consumer/non-health professional from United States on 2012-03-19

Patient: 66 year old female, weighing 59.0 kg (129.8 pounds)

Reactions: Abdominal Pain, Malaise, Vomiting, Fatigue, Cognitive Disorder, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fergon
    Administration route: Oral
    Indication: Iron Deficiency Anaemia
    Start date: 2009-02-27
    End date: 2009-08-28

Simvastatin
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Megace
    Administration route: Oral
    Indication: Appetite Disorder

Colace
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Sunitinib Malate
    Dosage: tab
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Pioglitazone HCL
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Ranitidine
    Indication: Ulcer
    End date: 2009-08-28

Zofran
    Dosage: tabs. every 6 hours;tabs 1df= every 6 hrs as needed
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Lortab
    Dosage: every 6 hours;1df=every 6 hrs 25aug09-28aug09 (3 days)
    Indication: Analgesic Therapy
    Start date: 2009-04-02
    End date: 2009-06-28

Other drugs received by patient: Artificial Tears; Ciprofloxacin Hydrochloride; Extra Strength Tylenol; Actonel; Aspirin



Possible Megace side effects in 56 year old female

Reported by a consumer/non-health professional from United States on 2012-03-19

Patient: 56 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-01-01
    End date: 2011-11-01

Prempro
    Dosage: 1 df: 0.625mg/2.5mg
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Paclitaxel
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Axitinib
    Dosage: 3mg twice/daily
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-05

Celebrex
    Administration route: Oral
    Indication: Arthritis
    Start date: 1997-01-01
    End date: 2011-11-01

Metoprolol Tartrate
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Megace
    Dosage: 1 df: 5cc 5ml/day from 28nov11
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Other drugs received by patient: MS Contin; Zofran; Benadryl; Wellbutrin



Possible Megace side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-16

Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)

Reactions: Uterine Leiomyoma, Haemorrhagic Anaemia, Gastrooesophageal Reflux Disease, Hypokalaemia, Vaginal Haemorrhage

Drug(s) suspected as cause:
Megace
    Dosage: 5 cc (5,4 in 1 d), oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-11-28

Megace
    Dosage: 5 cc (5,4 in 1 d), oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27

Celecoxib
    Dosage: 200 mg (200 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Paclitaxel
    Dosage: 10.2381 mg (215 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Metoprolol Tartrate
    Dosage: 25 mg (25 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16

Carboplatin
    Dosage: 26.9048 mg (565 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Prempro
    Dosage: 0.625mg/2.5mg (1 in 1 d), oral
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Axitinib (Axitinib)
    Dosage: 2 dosage forms (1 dosage forms, 2 in 1 d), oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-11-30

Other drugs received by patient: Wellbutrin (Bupropion0; Benadryl; Zofran; MS Contin



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-08

Patient: female, weighing 83.8 kg (184.3 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Megace
    Dosage: 5cc, 1x/day
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Prempro
    Dosage: 0.625 mg/2.5 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Axitinib
    Dosage: 3 mg, 2x/day,1 df
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Paclitaxel
    Dosage: 215 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral

Axitinib
    Dosage: 3 mg, 2x/day, continuously
    Administration route: Oral
    Start date: 2011-11-30

Megace
    Dosage: 5 cc, 1x/day
    Administration route: Oral
    Start date: 2011-11-28

Metoprolol Tartrate
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Carboplatin
    Dosage: 565 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Other drugs received by patient: Wellbutrin; Benadryl; Zofran; MS Contin



Possible Megace side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07

Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)

Reactions: Uterine Leiomyoma, Haemorrhagic Anaemia, Gastrooesophageal Reflux Disease, Decreased Appetite, Vaginal Haemorrhage, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Axitinb (Axitinib)
    Dosage: 2 dosage forms (1 dosage forms,2 in 1 d),oral ; 6 mg (3 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Axitinb (Axitinib)
    Dosage: 2 dosage forms (1 dosage forms,2 in 1 d),oral ; 6 mg (3 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-11-30

Carboplatin
    Dosage: 26.9048 mg (565 mg,1 in 3 wk),intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Megace
    Dosage: 5 cc (5, 4 in 1 d),oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27

Metoprolol Tartrate
    Dosage: 25 mg (25 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16

Celecoxib
    Dosage: 200 mg (200 mg,1 in 1 d),oral ; 200 mg (200 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Prempro
    Dosage: 0.625mg/2.5mg (1 in 1 d),oral
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Paclitaxel
    Dosage: 10.2381 mg (215 mg,1 in 3 wk),intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Other drugs received by patient: Benadryl; MS Contin; Wellbutrin; Zofran



Possible Megace side effects in 57 year old female

Reported by a consumer/non-health professional from United States on 2012-03-06

Patient: 57 year old female

Reactions: Disease Complication, Weight Decreased, Hepatitis C, Product Taste Abnormal

Adverse event resulted in: death

Drug(s) suspected as cause:
Megace



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05

Patient: female

Reactions: Abdominal Pain, Fatigue, Vomiting, Malaise, Headache, Cognitive Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Simvastatin
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Fergon
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2009-02-27
    End date: 2009-08-28

Pioglitazone Hydrochloride
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Colace
    Indication: Constipation
    Start date: 2009-03-02
    End date: 2009-08-28

Ranitidine
    Indication: Ulcer
    End date: 2009-08-28

Lortab
    Dosage: 5mg/500mg every 6 hours, as needed
    Indication: Analgesic Therapy
    Start date: 2009-03-02
    End date: 2009-08-28

Zofran
    Dosage: every 6 hours, as needed
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Sunitinib Malate
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Dutogliptin
    Dosage: investigational drug
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-03-16
    End date: 2009-04-06

Megace
    Dosage: daily
    Administration route: Oral
    Indication: Decreased Appetite

Other drugs received by patient: Actonel; Hypromellose; Cipro; Aspirin; Aspirin; Aspirin



Possible Megace side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02

Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)

Reactions: Abdominal Pain, Confusional State, Vomiting, Blood Urea Increased, Mental Status Changes, Cognitive Disorder, Headache, Malaise, Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zofran
    Dosage: 1 dosage forms, every 6 hrs, as needed, oral
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Megace
    Dosage: daily, oral
    Administration route: Oral
    Indication: Decreased Appetite

Fergon
    Dosage: 325 mg, 2 in 1 d, oral
    Administration route: Oral
    Indication: Blood Iron Decreased
    Start date: 2009-02-27
    End date: 2009-08-28

Dutoglipitin (Investigational Drug)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-03-16
    End date: 2009-04-06

Colace (Docusate Sodium)
    Dosage: 100 mg, 2 in 1 d
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Lortab
    Dosage: 5 mg/500 mg every 6 hrs, as needed
    Indication: Analgesic Therapy
    Start date: 2009-04-02
    End date: 2009-08-28

Sunitinib Malate
    Dosage: 100 mg, 2 in 1 d
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Pioglitazone Hydrochloride
    Dosage: 30 mg, oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Ranitidine Hydrochloride
    Dosage: 300 mg
    Indication: Ulcer
    End date: 2009-08-28

Simvastatin
    Dosage: 40 mg, 2 in 1 d
    Indication: Blood Cholesterol Increased
    Start date: 2009-02-27
    End date: 2009-08-28

Other drugs received by patient: Artificial Tear (Hypromellose); Cipro; Actonel; Aspirin



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02

Patient: female, weighing 83.8 kg (184.3 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 565 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Megace
    Dosage: 5 cc, 1x/day
    Administration route: Oral
    Start date: 2011-11-28

Axitinib
    Dosage: 3 mg, 2x/day,1 df
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Metoprolol Tartrate
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Paclitaxel
    Dosage: 215 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Prempro
    Dosage: 0.625 mg/2.5 mg, qd
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral

Megace
    Dosage: 5cc, qd
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Other drugs received by patient: Benadryl; Zofran; Wellbutrin; MS Contin



Possible Megace side effects in female

Reported by a physician from United States on 2012-02-27

Patient: female, weighing 59.4 kg (130.7 pounds)

Reactions: Abdominal Pain, Malaise, Vomiting, Fatigue, Cognitive Disorder, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Study Drug
    Dosage: unk
    Indication: Prophylaxis
    Start date: 2009-05-12
    End date: 2009-07-07

Lortab
    Dosage: 1 df, q6h prn
    Indication: Analgesic Therapy
    Start date: 2009-04-02
    End date: 2009-06-29

Simvastatin
    Dosage: 80 mg, daily
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Ranitidine
    Dosage: 300 mg, daily
    Indication: Ulcer
    End date: 2009-08-28

Zofran
    Dosage: 1 df, q6h prn
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Pioglitazone Hydrochloride
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Fergon
    Dosage: 650 mg, daily
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2009-02-27
    End date: 2009-08-28

Sunitinib Malate
    Dosage: 100 mg, daily
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Colace Capsules
    Dosage: 200 mg, daily
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Lortab
    Dosage: 1 df, q6h prn
    Start date: 2009-08-25
    End date: 2009-08-28

Megace
    Dosage: 3 df, daily
    Administration route: Oral
    Indication: Appetite Disorder

Radiation
    Dosage: every day, five days a week for three weeks
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-03-16
    End date: 2009-04-06

Other drugs received by patient: Artificial Tears / 00445101 /; Aspirin; Actonel; Aspirin; Aspirin; Tylenol (Caplet); Cipro



Possible Megace side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-24

Patient: 56 year old female, weighing 65.9 kg (145.0 pounds)

Reactions: Uterine Leiomyoma, Anaemia, Gastrooesophageal Reflux Disease, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoprolol Tartrate
    Dosage: 25 mg (25 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16

Axitinib (Axitinib)
    Dosage: 2 dosage forms (1 dosage forms, 2 in 1 d), oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-11-30

Celebrix (Celecoxib)
    Dosage: 200 mg (200 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-01-01
    End date: 2011-11-01

Prempro
    Dosage: 0.625 mg/2.5 mg (1 in 1 d), oral
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Carboplatin
    Dosage: 26.9048 mg (565 mg, 1 in 3 wk), intravenous
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20
    End date: 2011-10-20

Paclitaxel
    Dosage: 10.2381 mg (215 mg, 1 in 3 wk), intravenous
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20
    End date: 2011-10-20

Megace
    Dosage: 5 cc (1 in 1 d), oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27

Other drugs received by patient: Benadryl; Wellbutrin; Zofran; MS Contin; Megace; Celebrex



Possible Megace side effects in female

Reported by a physician from United States on 2012-02-23

Patient: female, weighing 59.4 kg (130.7 pounds)

Reactions: Abdominal Pain, Vomiting, Malaise, Fatigue, Headache, Cognitive Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ranitidine
    Dosage: 150 mg, 2x/day
    Indication: Ulcer
    End date: 2009-08-28

Zofran
    Dosage: 1 dosage forms, every 6 hrs
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Lortab
    Dosage: 1 dosage forms, every 6 hours
    Start date: 2009-08-25
    End date: 2009-08-28

Colace
    Dosage: 100 mg, 2x/day
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Fergon
    Dosage: 325 mg, 2x/day
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2009-02-27
    End date: 2009-08-28

Sunitinib Malate
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Megace
    Dosage: unk
    Administration route: Oral
    Indication: Appetite Disorder

Pioglitazone Hydrochloride
    Dosage: 30 mg, 1x/day
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Lortab
    Dosage: 1 dosage forms, every 6 hours
    Indication: Analgesic Therapy
    Start date: 2009-04-02
    End date: 2009-06-29

Simvastatin
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Other drugs received by patient: Ciprofloxacin; Actonel; Aspirin; Extra Strength Tylenol; Artificial Tears; Aspirin; Aspirin



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-22

Patient: female, weighing 65.9 kg (145.0 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Megace
    Dosage: 5cc, qd
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Axitinib
    Dosage: 3 mg, 2x/day,1 df
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma

Paclitaxel
    Dosage: 215 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Prempro
    Dosage: 0.625 mg/2.5 mg, qd
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Carboplatin
    Dosage: 565 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-01-01
    End date: 2011-11-01

Metoprolol Tartrate
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Celebrex
    Indication: Arthritis

Megace
    Dosage: 5 ml, 1x/day
    Start date: 2011-11-28

Other drugs received by patient: Wellbutrin; Zofran; Benadryl; MS Contin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012